Report: Biotech revenue, spending on R&D rose in 2011

09/26/2012 | PharmaTimes (U.K.) · Pharmalot.com

Biotech companies, on average, generated $76 million in revenues last year, up 24% compared with 2010, according to a report from consulting firm BDO USA. On average, research and development spending grew to $50 million from about $47 million in 2010. Major biotechs with revenues surpassing $50 million reported a 33% increase in revenue, but smaller biotechs reported a 12% decline.

View Full Article in:

PharmaTimes (U.K.) · Pharmalot.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA